Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - CASH FROM OPERATIONS
Cash from Operations AKBA - Akebia Therapeutics, Inc.
-23.4 M
LAST VALUE
69.60%
2 YEAR CAGR
24.84%
5 YEAR CAGR
-7.51%
10 YEAR CAGR